Altshuler Shaham’s Repligen RGEN Stock Holding History

Altshuler Shaham’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-196	Closed	-$38K	–	522
2020 Q4	$38K	Buy	196 +19	+11%	+$3.46K	﹤0.01%	315
2020 Q3	$26K	Buy	177 +20	+13%	+$2.86K	﹤0.01%	302
2020 Q2	$19K	Buy	+157	New	+$18.5K	﹤0.01%	264

Other funds holding RGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Altshuler Shaham's RGEN Position: Q1 2021 in Review

Altshuler Shaham sold out of Repligen (RGEN) in Q1 2021, closing a stake of 196 shares — an estimated $38K sold.

Altshuler Shaham first reported a position in RGEN in Q2 2020 and held it in 3 quarters. The position peaked at $38K in Q4 2020. 458 funds tracked by Wall St. Rank hold RGEN as of Q1 2021.

Altshuler Shaham reported no remaining Repligen position as of Q1 2021 after selling out during the quarter.
Altshuler Shaham sold 196 Repligen shares in Q1 2021, an estimated $38K.
Altshuler Shaham first reported a position in Repligen in Q2 2020 and held it in 3 quarters.
Altshuler Shaham's Repligen position peaked at $38K in Q4 2020.
458 funds tracked by Wall St. Rank held Repligen as of Q1 2021.

Based on Altshuler Shaham's 13F filing for Q1 2021, filed 13 May 2021.